Publikationen, an denen er mitarbeitet Ángel Ernesto Amesty Arrieta (29)

2023

  1. Labdane conjugates protect cardiomyocytes from doxorubicin-induced cardiotoxicity

    Drug Development Research, Vol. 84, Núm. 1, pp. 84-95

  2. Methyl esters of 23,24-Dinor-5α-cholan-22-oic acids as brassinosteroid Analogues. Synthesis, evaluation of plant growth promoting activity and Molecular docking

    Steroids, Vol. 196

  3. Phenolic and quinone methide nor-triterpenes as selective NLRP3 inflammasome inhibitors

    Bioorganic Chemistry, Vol. 132

  4. Synthesis and biological evaluation of anthracene-9,10 dione derivatives as CK2 inhibitors

    Results in Chemistry, Vol. 6

2022

  1. Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking

    Pharmaceuticals, Vol. 15, Núm. 7

  2. Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones

    Pharmaceuticals, Vol. 15, Núm. 5, pp. 585

  3. Discovery of Highly Functionalized 5-hydroxy-2H-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen

    Cancers, Vol. 14, Núm. 21

2021

  1. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

    Biomedicine and Pharmacotherapy, Vol. 144

  2. Modular synthesis and antiproliferative activity of new dihydro-1H-pyrazolo[1,3-b]pyridine embelin derivatives

    Pharmaceuticals, Vol. 14, Núm. 10

  3. Synthesis and fungicidal activity of hydrated geranylated phenols against botrytis cinerea

    Molecules, Vol. 26, Núm. 22

2020

  1. Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation

    Journal of Natural Products, Vol. 83, Núm. 7, pp. 2155-2164

  2. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors

    Bioorganic Chemistry, Vol. 95

  3. Development of an in vitro screening assay for PIP5K1α lipid kinase and identification of potent inhibitors

    FEBS Journal, Vol. 287, Núm. 14, pp. 3042-3064

  4. Efficient Multicomponent Synthesis of Diverse Antibacterial Embelin-Privileged Structure Conjugates

    Molecules (Basel, Switzerland), Vol. 25, Núm. 14

2019

  1. A novel naphthoquinone-coumarin hybrid that inhibits BCR-ABL1-STAT5 oncogenic pathway and reduces survival in imatinib-resistant chronic myelogenous leukemia cells

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  2. Metal complexes of natural product like-compounds with antitumor activity

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 19, Núm. 1, pp. 48-65

  3. Synthesis and antiplasmodial activity of 1,2,3-triazole-naphthoquinone conjugates

    Molecules, Vol. 24, Núm. 21

  4. α-hispanolol induces apoptosis and suppresses migration and invasion of glioblastoma cells likely via downregulation of MMP-2/9 expression and p38MAPK attenuation

    Frontiers in Pharmacology, Vol. 10, Núm. JULY

2018

  1. A new family of densely functionalized fused-benzoquinones as potent human protein kinase CK2 inhibitors

    European Journal of Medicinal Chemistry, Vol. 144, pp. 410-423

  2. Opto-chemical and laser properties of FLTX1, a novel fluorescent tamoxifen derivative, and its potential applications in breast cancer photodynamic chemotherapy

    Optical Materials, Vol. 84, pp. 442-446